Funding news
NOVACYT logo

NOVACYT Secures $852

Recently funded · $852.0K UnknownHospitals and Health CareView source

Get the full NOVACYT company profile

Access contacts, investors, buying signals & more

Open in Dashboard

NOVACYT, the French specialist in fully automated liquid based cytology for cancer screening, has secured $852K in new funding. Founded in 2006 by an experienced team from biotech and industrial companies, the Vélizy-Villacoublay-based firm develops and markets advanced solutions designed to improve laboratory workflow and throughput.

Recognized as a highly innovative company by GENOPOLE and OSEO, NOVACYT positions itself as a market leader with proprietary equipment and devices. Its multipurpose platform streamlines GYN and NON GYN cytology, multi slide preparation, and pre-aliquoting for reflex testing by molecular biology, increasing laboratory efficiency.

Other recently funded companies

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Unknown rounds

Companies that recently closed a Unknown round.

#CompanyAmount
1
Repligen Corporation logo

Repligen Corporation

United States

$290.1M
2
Funderbeam logo

Funderbeam

United Kingdom

$40.0M
3
Unity logo

Unity

United States

$1.3B
4
Spintop Ventures logo

Spintop Ventures

Sweden

$188.3M
5
AHL Venture Partners logo

AHL Venture Partners

Kenya

$30.5M